COVID-19.Using a virtual screening of the DrugBank database, the research published in the journal Scientific Reports, identified a variety of as yet unexplored ways to attack SARS-CoV-2, even as it mutates.The Drugbank database is a chemical space of compounds approved by FDA and molecules under drug trials.Also read: The pandemic push to the silver economyThe researchers from Alagappa University in Tamil Nadu and KTH Royal Institute of Technology, Sweden propose a list of individual drugs and cocktails that deserve testing for the treatment of COVID-19.A key part of the study, the researchers said, is the identification of drugs that target or bind to multiple proteins that are essential for replication of the virus, and which are also.